AJ

Active Director Director DIN 06945340
DIN 06945340 First appointment Sep 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2014
Shareholding value •••• Premium profile

About Anita Jha

Data last updated:

Anita Jha is a Director at Daffoworth Pharmaceutical Private Limited (since 2014). The company operates in Pharma. Daffoworth Pharmaceutical Private Limited reported revenue of ₹5.24 Cr (FY 2025).

DIN 06945340
Primary Designation Director
Industry Pharma
First Appointment 09 Sep 2014
Oldest Company Age 12 yrs
Largest company Daffoworth Pharmaceutical Private Limited · ₹5.24 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Sep 20142014₹5.24 Cr (FY 2025)Active

Board colleagues of Anita Jha

NameDINCompanyDesignation
Dharmendra Kumar Jha06418599Daffoworth Pharmaceutical Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Daffoworth Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Anita Jha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anita Jha

Anita Jha currently holds 1 directorship: Daffoworth Pharmaceutical Private Limited (Director, since 09 Sep 2014, revenue ₹5.24 Cr (FY 2025)).

Anita Jha was first appointed on 09 Sep 2014 as Director at Daffoworth Pharmaceutical Private Limited.

The current boards of Anita Jha's companies include Dharmendra Kumar Jha (Daffoworth Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available